This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Choroidal coloboma (ocular coloboma)Choroidal Coloboma (Ocular Coloboma)

Contents and key points
ItemDetails
A. Classification codesICD-10: H31.2 | Special Copayment Reduction: V295 (5 years)
B. SynonymsChoroidal coloboma, ocular coloboma, chorioretinal coloboma, optic nerve coloboma
C. Adult onsetLikelihood of first onset in adulthood very low — a congenital developmental anomaly determined by failure of optic cup closure at 5–7 weeks of gestation
1. HistoryClinical description after the introduction of the ophthalmoscope in the early 19th century; description of CHARGE syndrome (1979, Hall/Hittner); identification of the CHD7 gene (2004)
2. CausesIncomplete closure of the inferior embryonic fissure of the optic cup at 5–7 weeks of gestation → defects of the choroid, retina, optic nerve, and iris; unilateral to bilateral, variable extent
3. GeneticsPAX6, CHD7 (CHARGE syndrome), PAX2, SHH, BCOR, GDF6, STRA6, VSX2, etc.; autosomal dominant, recessive, X-linked, sporadic; associated with chromosomal abnormalities
4. Epidemiology0.5–2.6 per 10,000 births; about 3–11% of causes of congenital blindness; about 60% bilateral; similar in males and females; about 75% sporadic
5. PathophysiologyFailure of closure of the inferior embryonic (choroidal) fissure of the optic cup; disruption of PAX6, SHH, and FGF signaling → failure of mesodermal migration → defects of the choroid, RPE, and neural layer
6. SymptomsAsymptomatic to severe visual impairment depending on defect location and extent; permanent visual impairment with macular or optic nerve involvement; sudden vision loss when complicated by retinal detachment
7. SignsFundus: inferonasal white defect area (no choroid or RPE); microphthalmia, iris coloboma (keyhole pupil), enlarged optic disc cup; checking for associated malformations essential
8. ScreeningNeonatal red reflex test, ophthalmoscopy, screening for associated malformations of CHARGE and VACTERL syndromes; prenatal ultrasound (after 20 weeks of gestation)
9. DiagnosisFundus examination + fundus photography + B-scan ultrasound + OCT; differentiation of associated systemic syndromes (CHARGE, COACH, trisomy 13, etc.); gene panel
10. TreatmentCurrently no curative treatment; prophylactic laser for retinal detachment, surgery (vitrectomy for detachment); correction of refractive errors; low vision rehabilitation; amblyopia treatment
11. PrognosisMacular and optic nerve involvement determine visual prognosis; retinal detachment complication rate 20–40%; relatively favorable if the macula is spared; continuous follow-up needed
12. PreventionFolic acid supplementation in early pregnancy, avoidance of embryonic toxins (alcohol, certain drugs); genetic counseling; prenatal diagnosis; early detection in the neonatal period and linkage to rehabilitation
13. References10 references listed with PMID/DOI (below)

1. Historical background

Ocular coloboma derives from the Greek 'koloboma' (something cut off) and refers to a condition in which a particular part of the eye's structure is missing. Clinical description began in earnest after the introduction of the ophthalmoscope in the early 19th century, by Helmholtz (1851) and others. In the late 19th century, the association between coloboma and failure of closure of the inferior embryonic fissure during embryonic optic cup development was established anatomically.

CHARGE syndrome (Coloboma, Heart defects, Atresia of choanae, Retardation, Genital abnormalities, Ear anomalies) was described independently by Hall and Hittner in 1979, with coloboma included as one of the major diagnostic criteria. In 2004, Vissers et al. established that variants of the CHD7 (chromodomain helicase DNA-binding protein 7) gene are the main cause of CHARGE syndrome, marking a turning point in research on its molecular pathogenesis. Subsequently, various genes such as PAX2, PAX6, SHH, GDF6, BCOR, STRA6, and VSX2 were found to be associated with isolated and syndromic coloboma. In the 2020s, advances in genome sequencing technology have made it possible to identify pathogenic variants in about 40–50% of colobomas.

2. Causes

The direct cause of choroidal coloboma is incomplete closure of the embryonic fissure (or choroidal fissure) that forms in the inferior optic cup during fetal development. In normal development, the optic cup forms by invagination from the ectoderm at 4–5 weeks of gestation, and the fissure in the inferior optic cup closes in stages at 5–7 weeks of gestation (33–45 days after fertilization). If this closure process fails partially or completely, defects of various structures, from the iris and ciliary body to the choroid, retina, and optic nerve, occur depending on their location and extent.

The defect is, as a rule, located in the inferonasal direction, reflecting the anatomical position of the embryonic fissure of the optic cup. The defect can occur anywhere from the optic nerve (posterior pole) to the iris (anterior pole), and the most common form is the posterior form with predominantly choroidal and retinal defects. The larger the defect, the more frequent the involvement of the macula and optic nerve, which is unfavorable for visual prognosis. Exposure to alcohol, vitamin A deficiency, and certain drugs such as cyclophosphamide in early pregnancy are known extrinsic risk factors, but the majority are developmental anomalies due to genetic predisposition.

3. Genetics

Ocular coloboma has very high genetic heterogeneity. The main genes identified to date are as follows.

Modes of inheritance vary — autosomal dominant (incomplete penetrance), autosomal recessive and X-linked — and about 75% of cases are sporadic without a family history. Chromosomal abnormalities (trisomy 13, trisomy 18, 4p deletion, CHARGE-related 8q abnormalities, etc.) are also associated with coloboma.

4. General epidemiology

The birth prevalence of ocular coloboma is estimated at 0.5–2.6 per 10,000 births depending on the report. Worldwide, about 20,000–30,000 patients with coloboma are estimated to be born each year, accounting for about 3–11% of causes of congenital visual impairment. Optic cup developmental anomalies in the broad sense including microphthalmia (MAC, microphthalmia-anophthalmia-coloboma) are reported at about 1 per 10,000 (10 per 100,000).

About 60% are bilateral, and in unilateral cases there is no left–right difference. The sex distribution is generally similar, but some studies show a slight male predominance. Isolated coloboma accounts for about 40–50%, and the rest are syndromic forms associated with CHARGE syndrome, microphthalmia or other systemic malformations. A family history is identified in about 25%. The familial recurrence risk for sporadic cases is roughly 5–15%.

5. Pathophysiology

The pathophysiology of choroidal coloboma is explained by molecular disruption of optic cup formation and embryonic fissure closure.

Optic cup formation and embryonic fissure closure

At 4–5 weeks of development, the optic vesicle of the neuroectoderm invaginates to form the double-layered optic cup. On the inferior side of the optic cup is the embryonic (choroidal) fissure through which blood vessels pass, and the hyaloid artery enters the eye through this fissure. At 5–7 weeks of development, the embryonic fissure gradually closes from front to back (anteroposterior). If this closure is not completed, an area in which the choroid, RPE and neural retina have not formed (coloboma) remains at the defect site.

Dysregulation of molecular signaling

PAX6, PAX2, SHH, FGF, BMP (GDF6) and VAX transcription factors and morphogenetic signaling pathways are essential for embryonic fissure closure. PAX2 defines the inferior boundary in the optic nerve primordium and is involved in initiating closure, and PAX6 acts to suppress ventral optic cup fate determination. SHH signaling regulates inferior optic cup identity, and BMP/GDF6 regulates differentiation from the outer layer of the optic cup (future RPE) to the inner layer (future neural retina). The CHD7 protein regulates chromatin accessibility so that this transcriptional network operates accurately. Failure of mesodermal cells to migrate to the inferior optic cup can also cause incomplete closure.

6. Symptoms

The symptoms of coloboma range from asymptomatic to severe visual impairment depending on the location and extent of the defect and whether associated structural abnormalities are present.

Vision-related symptoms

Complication-related symptoms

Symptoms of associated malformations

When accompanied by CHARGE syndrome, systemic symptoms such as hearing loss, cardiac malformations and developmental delay can become the main clinical problems. When coloboma is found, associated systemic malformations must always be evaluated.

7. Signs

Funduscopic findings

Anterior segment signs

8. Screening

Early detection of coloboma is important for preventing complications and for the timing of starting rehabilitation.

9. Diagnosis

The diagnosis of coloboma is mostly established by clinical fundus findings.

Ophthalmologic diagnosis

Systemic evaluation

Differential diagnosis

10. Treatment

There is currently no fundamental treatment for choroidal coloboma. Treatment aims at preventing and managing complications and maximizing residual vision.

Treatment of complications

Visual rehabilitation

Research stage

Research on stem cell-based reconstruction of the choroid and RPE and on gene correction (in vivo CRISPR) is under way at the preclinical stage, but considerable time will be needed before clinical application.

11. Prognosis

The visual prognosis of coloboma is determined by whether the macula and optic nerve are involved. Peripheral colobomas that do not involve the macula can maintain normal or near-normal vision, and small defects may remain asymptomatic throughout life. In contrast, defects that include the macula or optic nerve cause permanent central visual impairment.

Patients with coloboma have a lifetime risk of retinal detachment of about 20–40%, which is a major factor in worsening prognosis. The surgical success rate for coloboma-related retinal detachment is lower than for ordinary retinal detachment because of anatomical structural abnormalities. When systemic abnormalities such as CHARGE syndrome are present, systemic complications such as cardiac and hearing problems affect the overall prognosis. Long-term follow-up and patient education about symptoms of retinal detachment (floaters, photopsia, visual field loss) are essential.

12. Prevention

Coloboma is a congenital developmental anomaly and is mostly not preventable. The following general recommendations apply.

13. References

  1. Chang L, Blain D, Bertuzzi S, Brooks BP. Uveal coloboma: clinical and basic science update. Curr Opin Ophthalmol. 2006;17(5):447-470. PMID: 16932065
  2. Stoll C, et al. Epidemiology of congenital eye malformations in 131,760 consecutive births. Ophthalmic Genet. 1997;18(3):119-123. PMID: 9361156
  3. Pagon RA. Ocular coloboma. Surv Ophthalmol. 1981;25(4):223-236. PMID: 7466397
  4. Vissers LE, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004;36(9):955-957. PMID: 15300250
  5. Bhatt DK, et al. Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes. Hum Genet. 2020;139(8):951-964. PMC: 7310839
  6. Kanwar JR, et al. Ocular manifestations of CHARGE syndrome in a pediatric cohort with genotype/phenotype analysis. Am J Med Genet A. 2024;188(8):2391-2402. PMID: 38597178
  7. Trider CL, et al. Understanding CHARGE syndrome. Am J Med Genet A. 2017;173(2):506-515. PMID: 27813300
  8. Skalicky SE, et al. Microphthalmia, anophthalmia, and coloboma and associated systemic findings. JAMA Ophthalmol. 2013;131(12):1517-1524. PMID: 24113667
  9. Gregory-Evans CY, et al. Ocular coloboma: a reassessment in the age of molecular neuroscience. J Med Genet. 2004;41(12):881-891. PMID: 15591271
  10. Bakri SJ, et al. Retinal detachment in ocular coloboma: surgical outcomes and prognosis. Retina. 2008;28(6):805-811. PMID: 18463524